Related Experiment Videos

Cardiovascular disease in type 2 diabetes mellitus: current management guidelines

Arshag D Mooradian1

  • 1Division of Endocrinology, Department of Internal Medicine, St Louis University School of Medicine, St Louis, MO 63104, USA. mooradad@slu.edu

Archives of Internal Medicine
|January 14, 2003
PubMed

Insights

Diabetic patients face high cardiovascular disease risks, similar to those with prior heart attacks. Stricter management of hyperglycemia, hypertension, and dyslipidemia is crucial for improving outcomes in diabetes mellitus.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Cardiovascular disease (CVD) is a primary complication of diabetes mellitus (DM).
  • Diabetic patients without prior cardiac events exhibit CVD mortality rates comparable to non-diabetic individuals with a history of myocardial infarction.
  • Increased CVD risk in diabetics stems from protein glycation/oxidation and prevalent risk factors like hypertension, obesity, and dyslipidemia.

Purpose of the Study:

  • To review landmark clinical trials on managing coronary risk factors in diabetic patients.
  • To suggest practical management guidelines for reducing cardiovascular events in diabetes.

Main Methods:

  • Review of recently published clinical trials focused on managing coronary risk factors.
  • Analysis of factors contributing to increased cardiovascular risk in diabetic populations.
  • Synthesis of evidence to propose updated therapeutic goals.

Main Results:

  • Despite advances, many diabetic patients have uncontrolled hyperglycemia, hypertension, and dyslipidemia.
  • Standard cardiovascular interventions may not be optimal for diabetic patients.
  • Emerging data suggest more stringent therapeutic targets are necessary for diabetic individuals.

Conclusions:

  • Diabetic patients require aggressive management of cardiovascular risk factors.
  • Tailored therapeutic strategies and stricter control goals are essential for mitigating cardiovascular mortality in diabetes.
  • Further research and clinical implementation of evidence-based guidelines are needed to improve cardiovascular outcomes in diabetes mellitus.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.